You just read:

IRX Therapeutics and ImmunID Announce Collaboration to Predict Response to IRX-2 Cancer Immunotherapy Using ImmunTraCkeR®

News provided by

ImmunID & IRX Therapeutics

Jan 19, 2016, 08:35 ET